Ordering Publications

To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:

Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535

Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.

Publications List (H-K)

(A list of all publications is available as an .rtf file).

Hall, E., Baldwin, D. M., & Prendergast, M. L. (2001). Women on parole: barriers to success after substance abuse treatment. Human Organization, 60(3), 225-233. (21.27)

Harlow, L. L., & Anglin, M. D. (1984). Time series design to evaluate effectiveness of methadone maintenance intervention. Journal of Drug Education, 14(1), 53-72. (10.5)

Hasson, A., Grella, C. E., Rawson, R., & Anglin, M. D. (1994). Case management within a methadone maintenance program. A research demonstration project for HIV risk reduction. Journal of Case Management, 3(4), 167-172. (10.23)

Hegamin, A., Anglin, G., & Casanova, M. (2002). Deconstructing the concept of "special populations". Journal of Drug Issues, 32(3), 825-836. (13.35)

Hegamin, A., Anglin, G., & Farabee, D. (2000). Gender differences in the perception of drug treatment: An examination of drug treatment services delivered to California youth authority wards. UCLA DARC White Paper. (15.9)

Hegamin, A., Anglin, G., & Farabee, D. (2001). Gender differences in the perception of drug user treatment: assessing drug user treatment for youthful offenders. Substance Use and Misuse, 36(14), 2159-2170. (14.08)

Hegamin, A., & Farabee, D. (2001). The utility of drug tests and infraction data in evaluating youth correctional treatment. Los Angeles: UCLA Drug Abuse Research Center. (13.29)

Hegamin, A., Farabee, D., & Monahan, G. (1999). Implementation of the CYA-RSAT Programs. A process evaluation of the California Youth Authority's Residential Substance Abuse Treatment (RSAT) Programs (Year 2). Sacramento, CA: Office of Criminal Justice Planning and The California Department of Youth Authority. (24.16)

Hegamin, A., Longshore, D., & Monahan, G. (2002). Health services in correctional settings: Emerging issues and model strategies. In: C. G. Leukefeld, F. M. Tims, & D. Farabee (Eds.), Treatment of Drug Offenders: Policies and Issues (pp. 335-347). New York: Springer Publishing Co. (03.27)

Henson, K. D., Longshore, D., Kowalewski, M. R., Anglin, M. D., & Annon, K. (1998). Perceived AIDS risk among adult arrestee injection drug users in Los Angeles County. AIDS Education and Prevention, 10(5), 447-464. (01.36)

Higgins, S. T., Roll, J. M., & Bickel, W. K. (1996). Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology, 123(1), 1-8. (27.8)

Hillhouse, M. P., & Fiorentine, R. (2001). 12-step program participation and effectiveness: do gender and ethnic differences exist? Journal of Drug Issues, 31(3), 767-780. (09.31)

Hoffman, V., & Anglin, M. D. (1997). Update on illicit drug use in Los Angeles County. Paper presented at the semi-annual meeting, Community Epidemiology Workgroup, Los Angeles, CA (08.5)

Hoffman, V., Annon, K., & Anglin, M. D. (1997). Update on illicit drug use in Los Angeles County. Paper presented at the semi-annual meeting, Community Epidemiology Workgroup, Los Angeles, CA. (08.6)

Hoffman, V., & Bolton, R. (1997). Reasons for having sex and sexual risk-taking: A study of heterosexual male STD clinic patients. AIDS Care, 3, 285-296. (01.31)

Hoffman, V., & Cohen, D. (1999). A night with Venus: partner assessments and high-risk sexual encounters. AIDS Care, 11(5), 555-566. (01.49)

Homer, J. B. (1993). Projecting the impact of law enforcement on cocaine prevalence: A system dynamics approach. Journal of Drug Issues, 23(2), 281-295. (12.19)

Homer, J. B. (1993). A system dynamics model for cocaine prevalence estimation and trend projection. Journal of Drug Issues, 23(2), 251-279. (12.18)

Homer, J. B. (1990). A system dynamics simulation model of cocaine prevalence. Unpublished manuscript, University of Southern California, University of California, Los Angeles. (12.5)

Horti, A. G., Chefer, S. I., Mukhin, A. G., Koren, A. O., Gundisch, D., Links, J. M., Kurian, V., Dannals, R. F., & London, E. D. (2000). 6-[f-18]fluoro-a-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sciences, 67(4), PL463-PL469. (30.14)

Horti, A. G., Koren, A. O., Lee, K. S., Mukhin, A. G., Vaupel, D. B., Kimes, A. S., Stratton, M., & London, E. D. (1999). Radiosynthesis and preliminary evaluation of 5-[i-123/125]iodo3-(2(s)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. Nuclear Medicine and Biology, 26(2), 175-182. (30.17)

Hser, Y. (1993). Data sources: Problems and issues. Journal of Drug Issues, 23(2), 217-228. (12.16)

Hser, Y. (1995). Drug treatment counselor practices and effectiveness: An examination of literature and relevant issues in a multilevel framework. Evaluation Review, 19(4), 389-408. (18.41)

Hser, Y. (1993). Population estimates of intravenous drug users and HIV infection in Los Angeles County. International Journal of the Addictions, 28(8), 695-709. (01.10)

Hser, Y. (1993). Population estimation of illicit drug users in Los Angeles County. Journal of Drug Issues, 23(2), 323-324. (12.21)

Hser, Y. (1993). Prevalence estimation: Summary of common problems and practical solutions. Journal of Drug Issues, 23(2), 335-343. (12.22)

Hser, Y. (1995). A referral system that matches drug users to treatment programs: Existing research and relevant issues. Journal of Drug Issues, 25(1), 209-224. (18.36)

Hser, Y. (1997). Self-reported drug use: Results of selected empirical investigations of validity. In: L. Harrison, & A. Hughes (Eds.), The validity of self-reported drug use: Improving the accuracy of survey estimates (NIDA Research Monograph 167, pp. 320-343). Rockville, MD: National Institute on Drug Abuse. (13.14)

Hser, Y., & Anglin, M. D. (2002). Book review [Review of the book Making research relevent and beyond. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment]. Contemporary Psychology: APA Review of Books, 47(1). (13.31)

Hser, Y., & Anglin, M. D. (1991). Cost-effectiveness of drug abuse treatment: Relevant issues and alternative longitudinal modeling approaches. In: W. S. Cartwright, & J. M. Kaple (Eds.), Economic costs, cost-effectiveness, financing, and community-based drug treatment (NIDA Research Monograph 113, pp. 67-93). Rockville, MD: National Institute on Drug Abuse. (18.20)

Hser, Y., & Anglin, M. D. (1992). A multi-method approach for estimating numbers of illicit drug users. In: Resource materials for state needs assessment studies (pp. 33-54). Washington, DC: Office for Treatment Improvement. (12.9)

Hser, Y., & Anglin, M. D. (1992). Patterns and consequences of narcotics addiction, final report. Washington, DC: National Institute on Drug Abuse. (03.9)

Hser, Y., Anglin, M. D., & Booth, M. W. (1987). Sex differences in addict careers. 3. Addiction. American Journal of Drug And Alcohol Abuse, 13(3), 231-251. (14.5)

Hser, Y., Anglin, M. D., & Chou, C. P. (1988). Evaluation of drug abuse treatment: A repeated measures design assessing methadone maintenance. Evaluation Review, 12(5), 547-570. (18.8)

Hser, Y., Anglin, M. D., & Chou, C. P. (1991). Narcotics use and crime among addicted women: Longitudinal patterns and effects of social interventions. In: T. Mieczkowski (Ed.), Drugs, crime, and social policy: Research, issues, and concerns (pp. 197-221). Boston: Allyn and Bacon. (21.4)

Hser, Y., Anglin, M. D., & Chou, C. P. (1992). Reliability of retrospective self-report by narcotics addicts. Psychological Assessment, 4(2), 207-213. (12.10)

Hser, Y., Anglin, M. D., & Fletcher, B. W. (1998). Comparative treatment effectiveness: Effects of program modality and client drug dependence history on drug use reduction. Journal of Substance Abuse Treatment, 15(1), 1-11. (24.1)

Hser, Y., Anglin, M. D., Grella, C. E., Longshore, D., & Prendergast, M. L. (1997). Drug treatment careers: A conceptual framework and existing research findings. Journal of Substance Abuse Treatment, 14(6), 543-558. (18.55)

Hser, Y., Anglin, M. D., & Liu, Y. (1990-1991). A survival analysis of gender and ethnic differences in responsiveness to methadone maintenance treatment. International Journal of the Addictions, 25(11A), 1295-1315. (09.3)

Hser, Y., Anglin, M. D., & McGlothlin, W. H. (1987). Sex differences in addict careers. 1. Initiation of use. American Journal of Drug and Alcohol Abuse, 13(1-2), 33-57. (14.6)

Hser, Y., Anglin, M. D., & Powers, K. I. (1993). A 24-year follow-up of California narcotics addicts. Archives of General Psychiatry, 50(7), 577-584. (03.8)

Hser, Y., Anglin, M. D., & Powers, K. I. (1990). Longitudinal patterns of alcohol use by narcotic addicts. In: M. Galanter (Ed.), Recent developments in alcoholism, Vol. III: Combined alcohol and other drug dependencies (pp. 145-171). New York: Plenum Press. (02.5)

Hser, Y., Anglin, M. D., Wickens, T. D., Brecht, M. L., & Homer, J. B. (1992). Techniques for the estimation of illicit drug-use prevalence: An overview of relevant issues. Washington, DC: National Institute of Justice. (12.11)

Hser, Y., Boyle, K., & Anglin, M. D. (1998). Drug use and correlates among STD patients, ER patients, and arrestees. Journal of Drug Issues, 28(2), 437-453. (20.6)

Hser, Y., Chou, C. P., & Anglin, M. D. (1990). The criminality of female narcotics addicts: A causal modeling approach. Journal of Quantitative Criminology, 6(2), 207-228. (21.3)

Hser. Y., Chou, C. P., Hoffman, V., & Anglin, M. D. (1999). Cocaine use and high-risk sexual behavior among STD clinic patients. Sexually Transmitted Diseases, 26(2), 82-86. (04.32)

Hser, Y., Grella, C. E., Chou, C. P., & Anglin, M. D. (1998). Relationships between drug treatment careers and outcomes: Findings from the National Drug Abuse Treatment Outcome Study. Evaluation Review, 22(4), 496-519. (18.64)

Hser, Y., Grella, C. E., Hsieh, S., Anglin, M. D., & Brown, B. S. (1999). Prior treatment experience related to process and outcomes in DATOS. Drug and Alcohol Dependence, 57(2), 137-150. (18.80)

Hser, Y., Grella, C. E., Hubbard, R. L., Hsieh, S., Fletcher, B. W., Brown, B. S., & Anglin, M. D. (2001). An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry, 58, 689-695. (25.1)

Hser. Y., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503-508. (03.11)

Hser. Y., Joshi, V., Anglin, M. D., & Fletcher, B. W. (1999). Predicting posttreatment cocaine abstinence for first-time admissions and treatment repeaters. American Journal of Public Health, 89(5), 666-671. (04.33)

Hser, Y., Joshi, V., Maglione, M. A., Chou, C. P., & Anglin, M. D. (2001). Effects of program and patient characteristics on retention of drug treatment patients. Evaluation and Program Planning, 24(4), 331-341. (13.22)

Hser, Y., Longshore, D., & Anglin, M. D. (1994). Prevalence of drug use among criminal offender populations: Implications for control, treatment, and policy. In: D. L. MacKenzie, & C. D. Uchida (Eds.), Drugs and the criminal justice system: Evaluating public policy initiatives (pp. 18-41). Thousand Oaks, CA: Sage Publications. (06.16)

Hser, Y., Maglione, M. A., & Boyle, K. (1999). Validity of self-report of drug use among STD patients, ER patients, and arrestees. American Journal of Drug and Alcohol Abuse, 25(1), 81-91. (20.7)

Hser, Y., Maglione, M. A., Polinsky, M. L., & Anglin, M. D. (1997). Predicting treatment entry among treatment-seeking drug abusers. Journal of Substance Abuse Treatment, 15(3), 213-220. (18.51)

Hser, Y., McCarthy, W. J., & Anglin, M. D. (1994). Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Preventive Medicine, 23(1), 61-69. (17.2)

Hser, Y., Polinsky, M. L., Maglione, M. A., & Anglin, M. D. (1999). Matching client's needs with drug treatment services. Journal of Substance Abuse Treatment, 16(4), 299-305. (24.2)

Hser, Y., Prendergast, M. L., Anglin, M. D., Chen, J., & Hsieh, S. (1998). A regression analysis estimating the number of drug using arrestees in 185 U.S. cities. American Journal of Public Health, 88(3), 487-490. (06.26)

Hser. Y., Shen, H., Chou, C. P., Messer, S. C., & Anglin, M. D. (2001). Analytic approaches for assessing long-term treatment effects. Evaluation Review, 25(2), 233-262. (18.93)

Hser. Y., Shen, H., Grella, C. E., & Anglin, M. D. (1999). Lifetime severity index for cocaine use disorder (LSI-Cocaine). Journal of Nervous and Mental Disease, 187(12), 742-750. (04.38)

Hser, Y., Stein, J. A., Maglione, M. A., & Polinsky, M. L. (1998). Predicting perceived quality of drug treatment programs using latent variable models. Evaluation and Program Planning, 21(1), 1-10. (18.54)

Hser, Y., & Yamaguchi, K. (1994). Relapse to narcotics addiction: An event-history analysis of intervention effects. Paper presented at the Proceedings of the 1993 annual meeting, American Statistical Association: (03.10)

Hser, Y., Yamaguchi, K., Chen, J., & Anglin, M. D. (1995). Effects of interventions on relapse to narcotics addiction: An event-history analysis. Evaluation Review, 19(2), 123-140. (18.27)

Hser Y.I., Grella C.E., Collins, C., & Teruya, C. (2003). Drug-use initiation and conduct disorder among adolescents in drug treatment. Journal of Adolescence, 26, 331-345. (05.22)

Huba, G. J. (1990). From theory to practice: The planned treatment of drug users. International Journal of the Addictions, 25(4), 445-469. (18.15)

Huber, A., Ling, W., Shoptaw, S., Gulati, V., Brethen, P., & Rawson, R. (1997). Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Diseases, 16(4), 41-50. (18.56)

Huber, A., Lord, R. H., Gulati, V., Marinelli-Casey, P., Rawson, R., & Ling, W. (2000). The CSAT methamphetamine treatment program: research design accommodations for "real world" application. Journal of Psychoactive Drugs, 32(2), 149-156. (28.21)

Hunt, D. E. (1987). Crack. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (04.3)

Isralowitz, R., Sussman, G., Afifi, M., Rawson, R., Babor, T., & Monteiro, M. (2001). Substance abuse policy and peace in the Middle East: a Palestinian and Israeli partnership. Addiction, 96, 973-980. (18.107)

Issari, P., & Coombs, R. H. (1998). Women, drug use, and drug testing. Journal of Sport and Social Issues, 22(2), 153-169. (21.23)

Jarvik, M. E. (1990). The drug dilemma: Manipulating the demand. Science, 250, 387-392. (13.9)

Johnson, B. A., Jasinski, D. R., Galloway, G. P. , Kranzler, H., Weinreib, R., Anton, R. F., Mason, B. J., Bohn, M. J., Pettinati, H. M., Rawson, R., & Clyde, C. (1996). Ritanserin in the treatment of alcohol dependence -- a multi-center clinical trial. Psychopharmacology, 128, 206-215. (02.18)

Johnson, P. B., Boles, S. M., & Kleber, H. D. (2000). The relationship between adolescent smoking and drinking and likelihood estimates of illicit drug use. Journal of Addictive Diseases, 19(2), 75-81. (05.6)

Johnson, P. B., Boles, S. M., Kleber, H. D., Vaughan, R., & McVeigh, K. H. (2000). Age-related differences in adolescent smokers' and nonsmokers' assessments of the relative addictiveness and health harmfulness of cigarettes, alcohol, and marijuana. Journal of Substance Abuse Treatment, 11(1), 45-52. (05.5)

Johnson, P. B., Boles, S. M., Vaughan, R., & Kleber, H. D. (2000). The co-occurrence of smoking and binge drinking in adolescence. Addictive Behaviors, 25(5), 779-783. (05.7)

Joshi, V., Grella, C. E., & Hser, Y. (2001). Drug use and treatment initiation patterns: Differences by birth-cohorts. Journal of Drug Issues, 31(4), 1039-1062. (13.21)

Joshi, V., Hser, Y., Grella, C. E., & Houlton, R. (2001). Sex-related HIV risk reduction behavior among adolescents in DATOS-A. Journal of Adolescent Research, 16(6), 642-660. (05.10)

Johnson, R. E., Strain, E. C., & Amass, L. (2003). Buprenorphine: How to use it right. Drug and Alcohol Dependence, 20(2, Suppl.1), S59-S77. (29.24)

Kalechstein, A., Newton, T., & Leavengood, A. H. (2002). Apathy syndrome in cocaine dependence. Psychiatry Research, 109(1), 97-100. (04.15)

Kalechstein, A., Newton, T., Longshore, D., Anglin, M. D., Van Gorp, W. G., & Gawin, F. H. (2000). Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences, 12(4), 480-484. (28.5)

Kamien, J. B., Bickel, W. K., Smith, B. J., Badger, G. J., & Hughes, J. R. (1997). Secobarbital in humans discriminating triazolam under two-response and novel-response procedures. Pharmacology, Biochemistry and Behavior, 58(4), 983-991. (13.25)

Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, M. E., & Paredes, A. (1997). Cocaine, crime, family history of deviance--Are psychosocial correlates related to these phenomena in male cocaine users? Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center: (04.31)

Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, M. E., & Paredes, A. (1999). Differential effects of treatment modality on psychosocial functioning of cocaine-dependent men. Journal of Clinical Psychology, 55(2), 257-274. (04.29)

Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, M. E., & Paredes, A. (1998). Variations in psychosocial functioning associated with patterns of progression in cocaine-dependent men. Addictive Behaviors, 23(2), 179-189. (04.34)

Kasarabada, N. D., Hser, Y., Boles, S. M., & Huang, Y. C. (2002). Do patients' perceptions of their counselors influence outcomes of drug treatment? Journal of Substance Abuse Treatment, 23, 327-334. (18.104)

Kasarabada, N. D., Hser, Y., Parker, L. E., Hall, E., Anglin, M. D., & Chang, E. (2001). A self-administered instrument for assessing therapeutic approaches of drug-user treatment counselors. Substance Use and Misuse, 36(3), 273-299. (13.23)

Katz, D. (1991). Geriatric use and misuse of medications. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (07.1)

Khalsa-Denison, M. E., Paredes, A., & Anglin, M. D. (1995). Correlates of post-treatment cocaine use reduction. (NIDA Research Monograph). Rockville, MD: National Institute on Drug Abuse. (04.5)

Khalsa-Denison, M. E., Paredes, A., & Anglin, M. D. (1995). A natural history assessment of cocaine dependence: Pre-and post-treatment behavioral patterns. (NIDA Research Monograph). Rockville, MD: National Institute on Drug Abuse. (04.27)

Khalsa, H. K., & Anglin, M. D. (1990). Substance abuse among the mentally ill: Developing treatment alternatives. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (15.2)

Khalsa, H. K., Anglin, M. D., & Paredes, A. (1992). Cocaine abuse: Outcomes of therapeutic interventions. Substance Abuse, 13(4), 165-179. (04.11)

Khalsa, H. K., Kowalewski, M. R., Anglin, M. D., & Wang, J. C. (1992). HIV-related risk behaviors among cocaine users. AIDS Education and Prevention, 4(1), 71-83. (01.11)

Khalsa, H. K., Paredes, A., & Anglin, M. D. (1992). The role of alcohol in cocaine dependence. In: M. Galanter (Ed.), Recent developments in alcoholism, Vol. 10: Alcohol and cocaine: Similarities and differences (pp. 7-35). New York: Plenum Press. (02.6)

Khalsa, H. K., Shaner, A., Anglin, M. D., & Wang, J. C. (1991). Prevalence of substance abuse in a psychiatric evaluation unit. Drug and Alcohol Dependence, 28(3), 215-223. (12.7)

Khalsa, M. E., & Anglin, M. D. (1991). Treatment effectiveness for cocaine abuse. In: United Nations Interregional Crime and Research Institute, Monograph Cocaine today and it's effects on the individual and society (pp. 89-98). UNICRI Publication No. 44. (18.17)

Khalsa, M. E., Anglin, M. D., Paredes, A., Potepan, P., & Potter, C. (1993). Pretreatment natural history of cocaine addiction: Preliminary 1-year follow-up results. In: F. M. Tims, & C. G. Leukefeld (Eds.), Cocaine treatment: Research and clinical perspectives (NIDA Research Monograph 135, pp. 218-236). Rockville, MD: National Institute on Drug Abuse. (18.16)

Khalsa, M. E., Kowalewski, M. R., Lunn, R., Anglin, M. D., & Miller, K. A. (1994). AIDS-related knowledge, beliefs and risk behaviors in a sample of crack addicts. Journal of Drug Issues, 24(3), 537-553. (01.18)

Khalsa, M. E., Miller, K. A., & Anglin, M. D. (1992). Cocaine-related problems as influences in patterns of cocaine use. (NIDA Research Monograph ). Rockville, MD: National Institute on Drug Abuse. (04.19)

Khalsa, M. E., Paredes, A., & Anglin, M. D. (1993). Cocaine dependence: Behavioral dimensions and patterns of progression. American Journal on Addictions, 2(4), 330-345. (04.13)

Khalsa, M. E., Paredes, A., Anglin, M. D., Potepan, P., & Potter, C. (1993). Combinations of treatment modalities and therapeutic outcome for cocaine dependence. In: F. M. Tims, & C. G. Leukefeld (Eds.), Cocaine treatment: Research and clinical perspectives (NIDA Research Monograph 135, pp. 237-259). Rockville, MD: National Institute on Drug Abuse. (04.26)

Khalsa, M. E., Tashkin, D. P., & Perrochet, B. (1992). Smoked cocaine: Patterns of use and pulmonary consequences. Journal of Psychoactive Drugs, 24(3), 265-272. (04.8)

Kimes, A. S., Horti, A. G., London, E. D., Chefer, S. I., Contoreggi, C., Ernst, M., Friello, P., Koren, A. O., Kurian, V., Matochik, J. A., Pavlova, O. A., Vaupel, D. B., & Mukhin, A. G. (2003). 2-[18F]F-A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB Journal, (30.23)

Kimes, A. S., Maldonado, R., Ambrosio, E., Koob, G. F., & London, E. D. (1998). Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus. Brain Research, 814(1-2), 1-12. (30.1)

Kirkish, P., Sreenivasan, S., Welsh, R. K., Van Gorp, W. G., Eth, S., Shoptaw, S., & Ling, W. (2000). The future of criminal violence: juveniles tried as adults. Journal of the American Academy of Psychiatry and the Law, 28(1), 38-46. (06.38)

Koren, A. O., Horti, A. G., Mukhin, A. G., Gundisch, D., Dannals, R. F., & London, E. D. (2000). Synthesis and initial in vitro characterization of 6-[f-18]fluoro-3-(2(s)-azetidinylmethoxy)pyridine, a high-affinity radioligand for central nicotinic acetylcholine receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 43(5), 413-423. (30.13)

Kowalewski, M. R., Henson, K. D., & Longshore, D. (1997). Rethinking perceived risk and health behavior: A critical review of HIV prevention research. Health Education and Behavior, 24(3), 313-325. (01.30)

Kowalewski, M. R., Khalsa, H. K., Anglin, M. D., & Cason, G. (1991). Assessment of HIV seroprevalence and behavior risk among cocaine users. Substance Abuse, 13(4), 180-187. (01.7)

Kowalewski, M. R., Longshore, D., & Anglin, M. D. (1994). The AIDS risk reduction model: Examining intentions to use condoms among injection drug users. Journal of Applied Social Psychology, 24(22), 2002-2027. (01.20)

Kronstadt, D. (1991). Issues of alcohol and drug use during pregnancy: Identifying and intervening with pregnant women. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (21.5)

Last updated - 02/11/2010

Top of Page

2015 ISAP Publications
2014 ISAP Biennial Report